- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01890317
Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction (SHOCK-COOL)
July 3, 2018 updated by: Holger Thiele, University of Leipzig
Randomized Pilot Study of Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction
Prospective, randomized, single-center, controlled, open-label Pilot-study to investigate whether induction of mild hypothermia in addition to primary percutaneous coronary intervention and optimal medical therapy in myocardial infarction complicated by cardiogenic shock improves cardiac power index after 24 h.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sachsen
-
Leipzig, Sachsen, Germany, 04289
- Department of Internal Medicine/Cardiology, University of Leipzig - Heart Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Acute myocardial infarction complicated by cardiongenic shock
- Patients on mechanical ventilation at time of randomization
Exclusion Criteria:
- Out of hospital resuscitation with indication for mild hypothermia
- mechanical complications after acute myocardial infarction
- duration of cardiogenic shock > 12 hours
- age > 90 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mild hypothermia
Induction of mild hypothermia for 24 hr with invasive cooling in addition to primary percutaneous coronary intervention and optimal medical therapy
|
Induction of mild hypothermia with invasive cooling for 24 hr in addition to primary percutaneous coronary intervention and optimal medical therapy.
|
No Intervention: Control
Percutaneous coronary intervention and optimal medical therapy according to current guidelines
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiac Power Index after 24 hr.
Time Frame: 24 hours
|
Cardiac Power Index after 24 hours as surrogate endpoint.
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of mechanical ventilation
Time Frame: 30 days
|
30 days
|
|
30-days mortality
Time Frame: 30 days
|
30 days
|
|
Change of hemodynamics over the first 48 hr.
Time Frame: During first 48 hr
|
During first 48 hr
|
|
Catecholamine dose and duration of catecholamine support
Time Frame: 30 days
|
30 days
|
|
Length of ICU-stay
Time Frame: 30 days
|
30 days
|
|
SAPS-II-Score
Time Frame: 96 hours
|
Simplified Acute Physiology Score for the first 4 days
|
96 hours
|
Severe and moderate bleeding complications (GUSTO-definition)
Time Frame: 30 days
|
30 days
|
|
Sepsis
Time Frame: 30 days
|
30 days
|
|
Pneumonia
Time Frame: 30 days
|
30 days
|
|
Stroke
Time Frame: 30 days
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Holger Thiele, MD, Heart Center Leipzig - University Hospital
- Principal Investigator: Georg Fuernau, MD, Heart Center Leipzig - University Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Cheng W, Fuernau G, Desch S, Freund A, Feistritzer HJ, Poss J, Buettner P, Thiele H. Circulating Monocyte Chemoattractant Protein-1 in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction Treated with Mild Hypothermia: A Biomarker Substudy of SHOCK-COOL Trial. J Cardiovasc Dev Dis. 2022 Aug 20;9(8):280. doi: 10.3390/jcdd9080280.
- Fuernau G, Beck J, Desch S, Eitel I, Jung C, Erbs S, Mangner N, Lurz P, Fengler K, Jobs A, Vonthein R, de Waha-Thiele S, Sandri M, Schuler G, Thiele H. Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction. Circulation. 2019 Jan 22;139(4):448-457. doi: 10.1161/CIRCULATIONAHA.117.032722.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2012
Primary Completion (Actual)
November 1, 2015
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
June 24, 2013
First Submitted That Met QC Criteria
June 26, 2013
First Posted (Estimate)
July 1, 2013
Study Record Updates
Last Update Posted (Actual)
July 6, 2018
Last Update Submitted That Met QC Criteria
July 3, 2018
Last Verified
July 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HZLCOOL1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiogenic Shock
-
University Hospital, MontpellierRecruiting
-
Odense University HospitalCharite University, Berlin, Germany; Hannover Medical School; Aarhus University... and other collaboratorsActive, not recruitingAcute Myocardial Infarction | Cardiogenic Shock AcuteGermany, Denmark, United Kingdom
-
Assaf-Harofeh Medical CenterUnknownMyocardial Infarction Complicated With Cardiogenic ShockIsrael
-
Hospices Civils de LyonCompleted
-
Wentworth Area Health ServicesAbbottUnknown
-
Universität MünsterNot yet recruiting
-
University of UtahUniversity of MinnesotaRecruiting
-
Windtree TherapeuticsMomentum Research, Inc.Not yet recruiting
-
Australian and New Zealand Intensive Care Research...Not yet recruitingCardiogenic Shock
Clinical Trials on Mild hypothermia
-
RenJi HospitalXiangya Hospital of Central South University; West China Hospital; Qilu Hospital... and other collaboratorsCompletedBrain Injuries | Craniocerebral TraumaChina
-
WellStar Health SystemWithdrawnIschemic Stroke | HypothermiaUnited States
-
University of MiamiTerminatedHypothermiaUnited States
-
Medivance, Inc.Completed
-
University Hospital Schleswig-HolsteinUniversity of Leipzig; University of Jena; University of Hamburg-EppendorfTerminated
-
University of AarhusCompletedCardiac Arrest | HypothermiaDenmark, Norway
-
University Hospital, BrestCompleted
-
Danish Procalcitonin Study GroupLundbeck Foundation; TRYG FoundationTerminatedSeptic ShockNetherlands, Denmark, United States
-
Imperial College LondonMedical Research CouncilCompletedHypoxia | Seizures | Asphyxia Neonatorum | EncephalopathyUnited Kingdom
-
Thomas Jefferson UniversityUnknownHypothermia | Cerebral HemorrhageUnited States